Are ACE inhibitors and ARBs more beneficial than harmful in the treatment of severe COVID-19 disease?

<p>After starting in China four months ago, the COVID-19 pandemic now affects most countries and has already caused more than 200,000 deaths by April 26, 2020</p><p>Under chest computerized tomography scans, the majority of severe COVID-19 patients show bilateral ground glass-like...

Full description

Saved in:
Bibliographic Details
Main Author: Christian A Devaux (Author)
Format: Book
Published: Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications, 2020-05-05.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_2455-2976_000122
042 |a dc 
100 1 0 |a Christian A Devaux  |e author 
245 0 0 |a Are ACE inhibitors and ARBs more beneficial than harmful in the treatment of severe COVID-19 disease? 
260 |b Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications,   |c 2020-05-05. 
520 |a <p>After starting in China four months ago, the COVID-19 pandemic now affects most countries and has already caused more than 200,000 deaths by April 26, 2020</p><p>Under chest computerized tomography scans, the majority of severe COVID-19 patients show bilateral ground glass-like opacities and subsegmental areas of consolidation indicative of pneumonia. If in its severe forms this disease affects the lungs, in many cases it is also responsible for a multi-organ failure with adverse myocardial remodeling, myocardial stress, and cardiomyopathy [1,2]. </p> 
540 |a Copyright © Christian A Devaux et al. 
546 |a en 
655 7 |a Opinion  |2 local 
856 4 1 |u https://doi.org/10.17352/2455-2976.000122  |z Connect to this object online.